Weekly Recap | Twist Bioscience +3.19%, consensus target below spotWeekly Review·Oct 3, 2026 at 08:40 AMTWST-6.78%
Weekly Recap | Alnylam Pharma -14.16%, one-way sellingWeekly Review·Oct 3, 2026 at 08:28 AMALNY+0.21%
Weekly Recap | RXRX.US +10.16%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:37 AMRXRX-7.78%
Weekly Recap | Roche -4.04%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:34 AMRHHBY+2.89%
Weekly Recap | PURR.US -7.47%, consensus target above spotWeekly Review·Oct 3, 2026 at 07:30 AMPURR-6.16%
Weekly Recap | Kodiak Sciences +191.96%, Zenkuda hits phase 3 goalWeekly Review·Oct 3, 2026 at 07:06 AMKOD-1.36%
